Skip to main content
Caplight Logo









23Mofang

23Mofang

Private
ChengduHealthcare & Life Scienceshttps://www.23mofang.com/

Last Round

VC Round

Aug 26, 2020

Est. Valuation

$37.2M

Total Funding Raised

$37.45M

Company Overview

23Mofang is a biotechnology company that provides direct-to-consumer genetic testing services, offering insights into ancestry, hereditary disease risks, and genetic traits.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Precision Medicine

Business Model

B2C

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

genetic testingDNA testancestry reportdirect-to-consumer genetic testingDTChealth risk assessmenttrait analysisDNA kitprecision medicinebioinformaticspersonal genomicsgenetic predispositionwellness testingconsumer biotechnologyspit kit

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

23Mofang Comparables

Compare 23Mofang with similar companies based on industry and business-model similarity.

23Mofang comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
WeGene
93%
Genebox
89%
GeseDNA Technology
85%

23Mofang Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 26, 2020
Series B ExtensionMay 31, 2018
Series B ExtensionMar 6, 2018
Series BAug 2, 2017
Series AJan 3, 2017
Pre Seed
Jan 12, 2016

23Mofang Investors

Notable investors and investment history

23Mofang investors
InvestorRounds
Fenghou CapitalAngel, Series B, Pre Seed
Bencao CapitalSeries B Extension
奇点资本Pre Seed
MPCSeries B Extension
Banyan Pacific CapitalSeries B Extension
SB China CapitalSeries B Extension
CD CapitalSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2018

    Raised $9.67M led by CD Capital.

  • Mar 6, 2018

    $16M round led by MPC

23Mofang Filings

Explore SEC and related filing metadata, where available.

23Mofang filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 23Mofang's valuation, stock price, and market status.

Is 23Mofang a public or private company?

23Mofang is a private company.

What is the current stock price of 23Mofang?

23Mofang is a private company with no public stock price. No recent secondary market data is available.

How much is 23Mofang worth (valuation)?

Valuation information for 23Mofang is not publicly available.

Can I buy 23Mofang stock?

23Mofang shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 23Mofang's last funding round?

23Mofang's most recent funding round was VC Round on August 26, 2020.

Who are the main investors in 23Mofang?

Key investors in 23Mofang include MPCi.

Will 23Mofang IPO soon?

No public IPO plans have been announced for 23Mofang.

How can I track 23Mofang secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 23Mofang's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChengdu
Employee Range1
Year Founded2015
Last FundingAug 26, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?